Skip to main content
. 2010 Apr 30;1(2):52–65. doi: 10.4021/wjon2010.04.200w

Table 5. Chemotherapy in advanced / metastatic pancreatic adenocarcinoma (Saif MW – Online CME “Treatment of pancreatic cancer) [101-104].

Study Gemcitabine regimen Median Survival (months) 1-year survival
Burris et al [102] 30-minute infusion 5.7 18%
Tempero et al [103] Fixed dose rate 7.8 24%
Louvet et al [104] Gemcitabine and Oxaliplatin 9.2 36%